Methylation status of Wnt signaling pathway genes affects the clinical outcome of Philadelphia-positive acute lymphoblastic leukemia

Cancer Science

Volumn 99, Issue 9, 2008, Pages 1865-1868

  Martin, Vanesa ^a   Agirre, Xabier ^b   Jiménez Velasco, Antonio ^c   José Eneriz, Edurne San ^b   Cordeu, Lucia ^b   Gárate, Leire ^b   Vilas Zornoza, Amaia ^b   Castillejo, Juan A ^a   Heiniger, Anabel ^c   Prósper, Felipe ^b   Torres, Antonio ^a   Roman Gomez, Jose ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN DKK3; PROTEIN HDPR1; PROTEIN WIF1; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 2; SECRETED FRIZZLED RELATED PROTEIN 4; SECRETED FRIZZLED RELATED PROTEIN 5; WNT PROTEIN; WNT5A PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MALE; OVERALL SURVIVAL; PHILADELPHIA CHROMOSOME POSITIVE CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RISK FACTORS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 50149117391     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00884.x     Document Type: Article

References (12)

1. Apostolidou E, Swords R, Alvarado Y, Giles FJ. Treatment of acute lymphoblastic leukaemia: A new era. Drugs 2007; 67: 2153-71.
2. Ribeiro RC, Broniscer A, Rivera GK et al. Philadelphia chromosome-positive acute lymphoblastic leukemia in children: Durable responses to chemotherapy associated with low initial white blood cell counts. Leukemia 1997; 11: 1493-6.
3. Roman-Gomez J, Jimenez-Velasco A, Agirre X et al. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol 2005; 23: 7043-9.
4. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA et al. Promoter hypermethylation of cancer-related genes: A strong independent prognostic factor in acute lymphoblastic leukemia. Blood 2004; 104: 2492-8.
5. Roman-Gomez J, Cordeu L, Agirre X et al. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 2007; 109: 3462-9.
6. Roman-Gomez J, Jimenez-Velasco A, Cordeu L et al. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia. Eur J Cancer 2007; 43: 2736-46.
7. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-6.
8. +) childhood acute lymphoblastic leukemia: Good initial steroid response allows early prediction of a favorable treatment outcome. Blood 1998; 92: 2730-41.
9. Rieder H, Ludwig WD, Gassmann W et al. Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia. Br J Haematol 1996; 95: 678-91.
10. Thomas X, Thiebaut A, Olteanu N et al. Philadelphia chromosome positive adult acute lymphoblastic leukemia: Characteristics, prognostic factors and treatment outcome. Hematol Cell Ther 1998; 40: 119-28.
11. Wetzler M, Dodge RK, Mrózek K et al. Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: A study of the Cancer and Leukaemia Group B. Br J Haematol 2004; 124: 275-88.
12. Yanada M, Takeuchi J, Sugiura I et al. Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy. Haematologica 2008; 93: 287-90.